Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peretz

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 18, 2005
Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of lifeO Paltiel, A Marzec-Boguslawska, V Soskolne, et al.
Nature Genetics|October 1, 1995
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individualsJ P Struewing, D Abeliovich, T Peretz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 19, 2007
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutationA Salmon, D Amikam, N Sodha, et al.
Nature Communications|November 25, 2015
PH motifs in PAR1&2 endow breast cancer growthA Kancharla, M Maoz, M Jaber, et al.
American Journal of Human Genetics|March 1, 1997
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi womenD Abeliovich, L Kaduri, I Lerer, et al.
British Journal of Cancer|June 11, 2008
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
Invasion & Metastasis|January 1, 1994
Inhibition of tumor metastasis by heparanase inhibiting species of heparinI Vlodavsky, M Mohsen, O Lider, et al.
American Journal of Human Genetics|June 23, 1998
The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extractionI Lerer, T Wang, T Peretz, et al.
Cytokine|March 2, 1999
Changes in cytokine production of breast cancer patients treated with interferonsV Barak, I Kalickman, B Nisman, et al.
British Journal of Cancer|December 1, 1991
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycinA Gabizon, R Chisin, S Amselem, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 18, 2005
Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of lifeO Paltiel, A Marzec-Boguslawska, V Soskolne, et al.
Nature Genetics|October 1, 1995
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individualsJ P Struewing, D Abeliovich, T Peretz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 19, 2007
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutationA Salmon, D Amikam, N Sodha, et al.
Nature Communications|November 25, 2015
PH motifs in PAR1&2 endow breast cancer growthA Kancharla, M Maoz, M Jaber, et al.
American Journal of Human Genetics|March 1, 1997
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi womenD Abeliovich, L Kaduri, I Lerer, et al.
British Journal of Cancer|June 11, 2008
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
Invasion & Metastasis|January 1, 1994
Inhibition of tumor metastasis by heparanase inhibiting species of heparinI Vlodavsky, M Mohsen, O Lider, et al.
American Journal of Human Genetics|June 23, 1998
The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extractionI Lerer, T Wang, T Peretz, et al.
Cytokine|March 2, 1999
Changes in cytokine production of breast cancer patients treated with interferonsV Barak, I Kalickman, B Nisman, et al.
British Journal of Cancer|December 1, 1991
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycinA Gabizon, R Chisin, S Amselem, et al.
Pageof 11